Skip to main content
. 2023 May 25;9(2):e12385. doi: 10.1002/trc2.12385

FIGURE 2.

FIGURE 2

Mechanisms of action of agents in Phase 3 (as classified using the CADRO approach). CADRO, Common Alzheimer's Disease Research Ontology; DMT, disease‐modifying therapy. (Figure © J Cummings; M de la Flor, PhD, Illustrator).